Abstract

Transcatheter (or percutaneous) renal denervation is a novel technique developed for the treatment of resistant hypertension. So far, only one randomised controlled trial has been published, which has shown a reduction of office blood pressure. The Swiss Society of Hypertension, the Swiss Society of Cardiology, The Swiss Society of Angiology and the Swiss Society of Interventional Radiology decided to establish recommendations to practicing physicians and specialists for good clinical practice. The eligibility of patients for transcatheter renal denervation needs (1.) confirmation of truly resistant hypertension, (2.) exclusion of secondary forms of hypertension, (3.) a multidisciplinary decision confirming the eligibility, (4.) facilities that guarantee procedural safety and (5.) a long-term follow-up of the patients, if possible in cooperation with a hypertension specialist. These steps are essential until long-term data on safety and efficacy are available.

Highlights

  • Arterial hypertension (HTN) is the most common cardiovascular risk factor

  • Transcatheter renal denervation is a novel technique developed for the treatment of resistant hypertension

  • Only one randomised controlled trial has been published, which has shown a reduction of office blood pressure

Read more

Summary

Summary

Transcatheter (or percutaneous) renal denervation is a novel technique developed for the treatment of resistant hypertension. The eligibility of patients for trancatheter renal denervation needs (1.) confirmation of truly resistant hypertension, (2.) exclusion of secondary forms of hypertension, (3.) a multidisciplinary decision confirming the eligibility, (4.) facilities that guarantee procedural safety and (5.) a long-term followup of the patients, if possible in cooperation with a hypertension specialist. These steps are essential until long-term data on safety and efficacy are available

Introduction
Pathophysiology and rationale for renal denervation
Covidien ballon
Safety of transcatheter renal denervation
Current limitations of transcatheter renal denervation
Findings
Perspectives of transcatheter renal denervation

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.